On March 03, CNS Pharmaceuticals Inc. (CNSP) announced its financial results for Q4 and fiscal 2021 along with corporate updates. In the following after-hours session,
CNS Pharmaceuticals Inc. (CNSP) stock rebounded in the after-hours on Friday, to add 12.47% at $0.79. Hence, the stock entered the new year in the
Shares of the CNS Pharmaceuticals, Inc. (CNSP) stock were climbing in the Pre-market today on June 18, 2021, following the announcement made by CNS pharmaceuticals
Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.